E. Kevin Hrusovsky - 05 Jul 2022 Form 4 Insider Report for Quanterix Corp (QTRX)

Reporting relationship: Executive Chairman, Director
Issuer ticker: QTRX
Reported as of: 05 Jul 2022
Net transaction value: -$15,906
SEC form: 4
Accepted by SEC: 06 Jul 2022, 16:07:44 UTC
Prior SEC filing: 17 Jun 2022
Next SEC filing: 22 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian Keane, as Attorney-in-Fact

Key filing fact

E. Kevin Hrusovsky filed Form 4 for Quanterix Corp (QTRX) on 06 Jul 2022.

Key facts

This page summarizes E. Kevin Hrusovsky's Form 4 filing for Quanterix Corp (QTRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2022, 16:07.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: -$15,906.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTRX transaction

Common Stock

Sale

Transaction value: $15,906
Shares: -960
Change %: -0.11%
Price: $16.57
Shares after: 910,249
Date: 05 Jul 2022
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F3

Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting.